Provided by Tiger Fintech (Singapore) Pte. Ltd.

AngioDynamics

9.29
-0.2900-3.03%
Pre-market: 9.890.6000+6.46%04:30 EDT
Volume:382.50K
Turnover:3.57M
Market Cap:377.24M
PE:-9.14
High:9.50
Open:9.48
Low:9.26
Close:9.58
Loading ...

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

Business Wire
·
06 Jan

AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ System

Business Wire
·
06 Jan

AngioDynamics Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
06 Jan

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
06 Jan

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
02 Jan

Press Release: AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event

Dow Jones
·
20 Dec 2024

PDCO Stock Gains on the News of Acquisition Deal With Patient Square

Zacks
·
16 Dec 2024

Baxter Stock May Gain Following Five New Injectable Product Launches

Zacks
·
13 Dec 2024

MBOT Stock Gains Following FDA Submission of the LIBERTY System

Zacks
·
13 Dec 2024

NSPR Stock May Gain as First Patient Enrolls in CGUARDIANS II Study

Zacks
·
12 Dec 2024

AngioDynamics Price Target Maintained With a $14.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Dec 2024

ANGO Stock Up Post FDA Nod for Prostate Tissue Ablation With NanoKnife

Zacks
·
11 Dec 2024

Here's Why You Should Add Accuray Stock in Your Portfolio Now

Zacks
·
11 Dec 2024

Strength Seen in AngioDynamics (ANGO): Can Its 23.3% Jump Turn into More Strength?

Zacks
·
10 Dec 2024

AngioDynamics Receives FDA Clearance for NanoKnife System, Poised for Growth with New Market Opportunities and Clinical Success

TIPRANKS
·
10 Dec 2024

ZYXI Stock Gains on the Completion of NiCO's Clinical Verification Trial

Zacks
·
10 Dec 2024

AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife

Dow Jones
·
09 Dec 2024

AngioDynamics Shares up 13.9% on US FDA Clearance of Prostate Cancer Treatment Device

THOMSON REUTERS
·
09 Dec 2024

BUZZ-AngioDynamics rises on US FDA clearance of prostate cancer treatment device

Reuters
·
09 Dec 2024

AngioDynamics receives FDA 510(k) clearance for NanoKnife System

TIPRANKS
·
09 Dec 2024